Approach 1 [„Dual Recordings] | ||||
---|---|---|---|---|
Mean [%/months] | SD [%/months] | Range [%/months] | P-value | |
subset B (carcinoma group) | ||||
female (n = 22) | 6.7 | 17.5 | −1.6 - 82.8 | 0.125 |
male (n = 4) | 4.9 | 2.3 | 2.0–7.3 | |
age < 50 years (n = 14) | 9.8 | 22.1 | −1.6 - 82.8 | 0.827 |
age ≥ 50 years (n = 12) | 2.9 | 2.9 | −0.7 - 11.3 | |
us type 2 or 3 (n = 7) | 2.8 | 2.5 | 0.1–7.3 | 0.979 |
us type 4 or 5 (n = 21) | 7.0 | 17.4 | −1.6 - 82.8 | |
subset C (adenoma group) | ||||
female (n = 22) | 3.4 | 3.96 | −2.0 - 12.0 | 0.525 |
male (n = 4) | 7.5 | 9.54 | −0.3 - 18.2 | |
age < 50 years (n = 12) | 3.4 | 3.44 | − 0.7 - 11.3 | 0.360 |
age ≥ 50 years (n = 14) | 3.9 | 5.14 | − 2.0 - 18.2 | |
us type 2 or 3 (n = 18) | 3.4 | 3.98 | −0.3 - 12.0 | 0.902 |
us type 4 or 5 (n = 8) | 4.0 | 5.33 | −2.0 - 18.2 |